Vortioxetine as adjunctive therapy in the treatment of schizophrenia

BACKGROUND: The evidence for safe and effective interventions to treat the negative and cognitive symptoms of schizophrenia is lacking. OBJECTIVES: Vortioxetine is a novel antidepressant that has been used as adjunctive therapy for the treatment of psychosis; however, its effectiveness in clinical p...

Descripción completa

Detalles Bibliográficos
Autores principales: Redaelli, Sofia, Porffy, Lilla, Oloyede, Ebenezer, Dzahini, Olubanke, Lewis, Gabriella, Lobo, Maria, Whiskey, Eromona, Shergill, Sukhi S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272178/
https://www.ncbi.nlm.nih.gov/pubmed/35833056
http://dx.doi.org/10.1177/20451253221110014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272178/
https://www.ncbi.nlm.nih.gov/pubmed/35833056
http://dx.doi.org/10.1177/20451253221110014

Ejemplares similares